Philip Mazzara, General Counsel and Secretary at , sold 9,900 shares of common stock on April 1, 2026, for a total value of $1.07 million. The sales occurred at weighted average prices ranging from $106.3426 to $110.346 per share.
The transactions, executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on May 29, 2025, involved multiple sales at varying prices. Specifically, 3,100 shares were sold at an average price of $106.3426, 1,985 shares at $107.5416, 3,415 shares at $108.4046, 1,000 shares at $109.156, and 500 shares at $110.346.
Following these transactions, Mazzara directly owns 118,084 shares of Astera LabsInc. common stock.The sales came as ALAB stock has experienced significant volatility, declining 42% over the past six months despite a strong 110% gain over the past year. The stock currently trades at $117.14, above Mazzara’s sale prices. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value, with 16 additional ProTips available to subscribers. Investors seeking deeper insights can access the comprehensive Pro Research Report, available for ALAB and 1,400+ US equities.
In other recent news, Astera Labs Inc. reported impressive financial results for the fourth quarter of 2025. The company exceeded earnings expectations with an earnings per share (EPS) of $0.58, which was 13.73% higher than the forecasted $0.51. Additionally, Astera Labs achieved a significant revenue milestone, reaching $270.6 million for the quarter. This represents a remarkable year-over-year revenue growth of 92%. These developments highlight Astera Labs’ strong performance in the market. The company’s financial achievements have drawn attention from investors and analysts alike. While the stock price movement is not discussed here, the earnings and revenue results are crucial indicators for stakeholders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Source:
www.investing.com
